About Pasithea Therapeutics Corp. Common Stock
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.
Market Cap
$0.00B
Employees
8
Listed Since
September 15, 2021
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.pasithea.comPhone
(702) 514-4174
Headquarters
1111 LINCOLN ROAD, SUITE 500
MIAMI BEACH, FL 33139
CIK
0001841330